BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35980655)

  • 21. 18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
    Rohde M; Dyrvig AK; Johansen J; Sørensen JA; Gerke O; Nielsen AL; Høilund-Carlsen PF; Godballe C
    Eur J Cancer; 2014 Sep; 50(13):2271-9. PubMed ID: 25011659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effects of Human Papillomavirus Status and Treatment on the Positive Predictive Value of Post-radiotherapy
    Zhou S; Chan C; Lau YC; Rulach R; Dyab H; Hendry F; Wilson C; Schipani S; Lamb C; Grose D; James A; Maxfield C; Dempsey MF; Paterson C
    Clin Oncol (R Coll Radiol); 2023 Dec; 35(12):e699-e707. PubMed ID: 37798198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PET/MR versus PET/CT for locoregional staging of oropharyngeal squamous cell cancer.
    Flygare L; Erdogan ST; Söderkvist K
    Acta Radiol; 2023 May; 64(5):1865-1872. PubMed ID: 36464816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study.
    Ryu IS; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2016 Aug; 63():88-96. PubMed ID: 27288873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-treatment FDG PET-CT in head and neck carcinoma: comparative analysis of 4 qualitative interpretative criteria in a large patient cohort.
    Zhong J; Sundersingh M; Dyker K; Currie S; Vaidyanathan S; Prestwich R; Scarsbrook A
    Sci Rep; 2020 Mar; 10(1):4086. PubMed ID: 32139722
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
    Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Accuracy of
    Murtojärvi S; Malaspina S; Kinnunen I; Tuokkola T; Honka MJ; Saunavaara V; Tolvanen T; Schrey A; Kemppainen J
    Contrast Media Mol Imaging; 2022; 2022():8676787. PubMed ID: 36082064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of response assessment fluorodeoxyglucose positron emission tomography-computed tomography scan in radically treated squamous cell carcinoma of head and neck: Long-term results of a prospective study.
    Ghosh-Laskar S; Mummudi N; Rangarajan V; Purandare N; Gupta T; Budrukkar A; Murthy V; Agarwal JP
    J Cancer Res Ther; 2019; 15(3):596-603. PubMed ID: 31169226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative
    Cho JK; Ow TJ; Lee AY; Smith RV; Schlecht NF; Schiff BA; Tassler AB; Lin J; Moadel RM; Valdivia A; Abraham T; Gulko E; Neimark M; Ustun B; Bello JA; Shifteh K
    Otolaryngol Head Neck Surg; 2017 Sep; 157(3):439-447. PubMed ID: 28608737
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Kim SA; Roh JL; Kim JS; Lee JH; Lee SH; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2017 Feb; 72():62-70. PubMed ID: 28027517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic value of diffusion-weighted imaging and
    Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of clinical and
    Cho JK; Hyun SH; Choi JY; Choi N; Kim MJ; Lee SH; Baek KH; Jeong HS
    J Surg Oncol; 2016 Dec; 114(7):888-894. PubMed ID: 27546387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Role of Positron Emission Tomography/Computed Tomography Imaging in Head and Neck Squamous Cell Carcinoma.
    Abdalla AS; Sheybani ND; Khan SA
    PET Clin; 2022 Apr; 17(2):213-222. PubMed ID: 35256298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma.
    Lee SH; Huh SH; Jin SM; Rho YS; Yoon DY; Park CH
    Otolaryngol Head Neck Surg; 2012 Oct; 147(4):692-8. PubMed ID: 22535915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
    Mani N; George MM; Nash L; Anwar B; Homer JJ
    Laryngoscope; 2016 Jun; 126(6):1354-8. PubMed ID: 26671043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.
    Kao J; Vu HL; Genden EM; Mocherla B; Park EE; Packer S; Som PM; Kostakoglu L
    Cancer; 2009 Oct; 115(19):4586-94. PubMed ID: 19544537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second-look PET-CT following an initial incomplete PET-CT response to (chemo)radiotherapy for head and neck squamous cell carcinoma.
    Prestwich RJD; Arunsingh M; Zhong J; Dyker KE; Vaidyanathan S; Scarsbrook AF
    Eur Radiol; 2020 Feb; 30(2):1212-1220. PubMed ID: 31485835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The response rate of PET-CT in the follow-up of head and neck squamous cell carcinoma patients.
    Laus M; Festa Kotelnikova E; Cazzato F; Buonamico A; Croce A
    Minerva Surg; 2022 Oct; 77(5):481-487. PubMed ID: 35230034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.